MedPath

The effect vitamin C supplementation on infertile women with polycystic ovary syndrome

Not Applicable
Conditions
Infertility, polycystic ovarian disease.
Female infertility associated with anovulation
Registration Number
IRCT2013030312672N1
Lead Sponsor
Shiraz University Of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
56
Inclusion Criteria

People who are willing to cooperate? Having 2 of 3 criteria Rotterdam; Women with at least one year before entering the study had tried unsuccessfully to conceive; women aged 35-18 years; Do not use alcohol; Not used hormonal drugs within the last 2 months; No abnormal bleeding; Women who still have a normal uterus and tubal; Normal Spermogram man; Disorders related to reproductive hormones; no history of pelvic surgery; The absence of Laparoscopic Surgery; Body Mass Index between 19/8 to 29
exclusion criteria: Unwillingness to continue working; sensitivity to vitamin c; abnormal bleeding.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
H. Timepoint: Day 3 of the first menstruation, second cycle Day 3, Day 3 of the third period. Method of measurement: ELIZA.;FSH. Timepoint: Day 3 of the first menstruation, second cycle Day 3, Day 3 of the third period. Method of measurement: ELIZA.;DHEAS. Timepoint: Day 3 of the first menstruation, second cycle Day 3, Day 3 of the third period. Method of measurement: ELIZA.;Testosterone. Timepoint: Day 3 of the first menstruation, second cycle Day 3, Day 3 of the third period. Method of measurement: ELIZA.;Estradiol. Timepoint: Day 3 of the first menstruation, second cycle Day 3, Day 3 of the third period. Method of measurement: ELIZA.;Progesteone. Timepoint: Day 22 of first cycle, Day 22 of the second cycle. Method of measurement: ELIZA.;SHBG. Timepoint: Day 3 of the first menstruation, second cycle Day 3, Day 3 of the third period. Method of measurement: ELIZA.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath